We demonstrated that ECOG PS <2, conduct of metastatic surgical treatment, and occurrence of maximum grade xerosis or folliculitis were predictive factors of cetuximab efficacy in KRAS wt mCRC patients. Here, KRAS is linked to folliculitis.